Topamax Tablet, Coated
Product Images NDC 50458-641

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Topamax (NDC 50458-641). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Janssen Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Chemical Structure (Topamax 01)

Chemical Structure (Topamax 01)
FDA Label Image

Figure 1 (Topamax 02)

Figure 1 (Topamax 02)
This is a graph displaying the cumulative rates for time to first seizure in patients treated with Topamax at two different doses (50mg/day and 400mg/day). The graph shows the time (in days) on the x-axis and the cumulative rates on the y-axis. The p-value for the comparison between the two doses is stated as 0.0002.*
FDA Label Image

Figure 2 (Topamax 03)

Figure 2 (Topamax 03)
The text seems to be a table showing the results of a study on TOPAMAX, a medication used for the prevention of migraines. The table includes the placebo dosage and different dosages of the medicine, and their effects on the average monthly migraine period rate. It also includes information about the change from the baseline to the double-blind phase of the study. The significance levels of the results are also reported.*
FDA Label Image

Principal Display Panel (25 mg Tablet Bottle Label)

Principal Display Panel (25 mg Tablet Bottle Label)
TopAMAX ® (topiramate) Tablets are prescription-only. It is recommended that the accompanying medication guide is dispensed to each customer before dispensing. The above text contains additional alphanumeric characters and is not readable.*
FDA Label Image

Principal Display Panel (50 mg Tablet Bottle Label)

Principal Display Panel (50 mg Tablet Bottle Label)
FDA Label Image

Principal Display Panel (100 mg Tablet Bottle Label)

Principal Display Panel (100 mg Tablet Bottle Label)
FDA Label Image

Principal Display Panel (200 mg Tablet Bottle Label)

Principal Display Panel (200 mg Tablet Bottle Label)
FDA Label Image

Principal Display Panel (15 mg Capsule Bottle Label)

Principal Display Panel (15 mg Capsule Bottle Label)
FDA Label Image

Principal Display Panel (25 mg Capsule Bottle Label)

Principal Display Panel (25 mg Capsule Bottle Label)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.